A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer-Reference-Cited by-同舟云学术

A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer

Published:2023-10 Issue: Volume:166 Page:115337
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Gupta Jitendra,Ahmed Abdulrahman T.,Tayyib Nahla A.,Zabibah Rahman S.,Shomurodov Qakhramon,Kadheim Mostafai N.,Alsaikhan Fahad,Ramaiah Pushpamala,Chinnasamy Lathamangeswari,Samarghandian Saeed

Funder

Prince Sattam bin Abdulaziz University

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference287 articles.

1. Cell death affecting the progression of gastric cancer;Wang;Cell Death Discov.,2022

2. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

3. Familial gastric cancer: genetic susceptibility, pathology, and implications for management;Oliveira;Lancet Oncol.,2015

4. Burden of gastric cancer;Thrift;Clin. Gastroenterol. Hepatol.,2020

5. Mapping the genomic diaspora of gastric cancer;Yeoh;Nat. Rev. Cancer,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment;Cancer Letters;2024-08

2. Homo and heteromultimetallic complexes containing a group 8 transition metal and μ-diphosphine bridging ligands involved in anticancer research: A review;European Journal of Medicinal Chemistry;2024-08

3. Meta-Analysis of the Efficacy and Safety of Pembrolizumab in the Treatment of Advanced Gastric Cancer and Gastroesophageal Junction Cancer;Chemotherapy;2024-07-17

4. Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials;BMC Cancer;2024-02-21

5. Quercetin suppresses ROS production and migration by specifically targeting Rac1 activation in gliomas;Frontiers in Pharmacology;2024-01-31